PATIENTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT

Clinical trials for PATIENTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT trials appear

Sign up with your email to follow new studies for PATIENTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug TS-172 tested in patients with liver disease

Knowledge-focused Recruiting now

This study looks at how the drug TS-172 behaves in people with mild or moderate liver impairment. Researchers will measure drug levels in the blood to understand how the liver affects the drug. The study involves 24 Japanese adults and is currently recruiting participants.

Matched conditions: PATIENTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT

Phase: PHASE1 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated Apr 26, 2026 19:35 UTC

PATIENTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT

Get alerted when new PATIENTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT trials appear

New drug TS-172 tested in patients with liver disease